Ausgabe 6/2019
Inhalt (32 Artikel)
Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis
F. Koohi, T. Kazemi, E. Miri-Moghaddam
Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network
Paolo Ricchi, Antonella Meloni, Chrysanthos Grigoratos, Patrizia Toia, Priscilla Fina, Laura Pistoia, Silvia Costantini, Zelia Borsellino, Roberto Lisi, Mario Rocca, Paolo Preziosi, Massimo Midiri, Alessia Pepe
Use of eltrombopag in aplastic anemia in Europe
Matyas Ecsedi, Étienne Lengline, Cora Knol-Bout, Paul Bosman, Dirk-Jan Eikema, Boris Afanasyev, Alexei Maschan, Peter Dreger, Constantijn J. M. Halkes, Beatrice Drexler, Agostino Cortelezzi, Bernard Drénou, Andrea Patriarca, Benedetto Bruno, Daniela Onofrillo, Edoardo Lanino, Drazen Pulanic, Ranka Serventi-Seiwerth, Alice Garnier, Per Ljungman, Francesca Bonifazi, Sabrina Giammarco, Olivier Tournilhac, Pietro Pioltelli, Alicia Rovó, Antonio M. Risitano, Régis Peffault de Latour, Carlo Dufour, Jakob Passweg
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study
N. J. Ames, J. J. Barb, A. Ranucci, H. Kim, S. E. Mudra, A. K. Cashion, D. M. Townsley, R. Childs, B. J. Paster, L. L. Faller, G. R. Wallen
Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome
Hidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, Jun Aoki, Takayuki Ishikawa, Naoyuki Uchida, Kazuteru Ohashi, Yasunori Ueda, Takahiro Fukuda, Toru Sakura, Yuju Ohno, Koji Iwato, Hirokazu Okumura, Tadakazu Kondo, Tatsuo Ichinohe, Minoko Takanashi, Yoshiko Atsuta, Yasushi Miyazaki
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Argiris Symeonidis, Ioannis Kotsianidis, Vassiliki Pappa, Athanasios Galanopoulos, Theodoros Vassilakopoulos, Maria Dimou, Eleni Solomou, Marie-Christine Kyrtsonis, Marina Siakantaris, Maria Angelopoulou, Alexandra Kourakli, Sotirios Papageorgiou, Georgia Christopoulou, Maria Roumelioti, Panayiotis Panayiotidis, Nora-Athina Viniou
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)
Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, Martina Crysandt, Jan-Henrik Mikesch, Saskia von Stillfried, Matthias Stelljes, Michele Pohlen, Georg Lenz, Anna Kirsch, Kerstin Vehring, Eva Wardelmann, Wolfgang Hartmann, Eike Bormann, Joachim Gerss, Tim H. Brümmendorf, Carsten Müller-Tidow, Wolfgang E. Berdel
Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low–middle-income country
Mecneide Mendes Lins, Maria Julia Gonçalves Mello, Raul C Ribeiro, Beatriz De Camargo, Maria de Fátima Pessoa Militão de Albuquerque, Luiz Claudio Santos Thuler
A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots
Bettina Kárai, Mira Habók, Gyula Reményi, László Rejtő, Anikó Ujfalusi, János Kappelmayer, Zsuzsanna Hevessy
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis
T. Demuynck, G. Verhoef, M. Delforge, P. Vandenberghe, Timothy Devos
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome
Georgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, Lemonia Velentza, Despina Fotiou, Dimitrios C. Ziogas, Ioannis Panagiotidis, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Anastasios Kallianos, Evangelos Terpos, Meletios A. Dimopoulos
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study
Maxime Jullien, Sabrina Trudel, Benoit Tessoulin, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Thomas Gastinne, Antoine Bonnet, Anne Lok, Amandine Lebourgeois, Pierre Peterlin, Alice Garnier, Patrice Chevalier, Thierry Guillaume, Patrick Thomaré, Steven Le Gouill, Philippe Moreau, Cyrille Touzeau
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
Sabrina Trudel, Benoît Tessoulin, Maxime Jullien, Nicolas Blin, Thomas Gastinne, Béatrice Mahé, Viviane Dubruille, Antoine Bonnet, Anne Lok, Patrice Chevallier, Pierre Peterlin, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Steven Le Gouill, Philippe Moreau, Cyrille Touzeau
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients
Francesco Gaudio, Patrizio Mazza, Anna Mele, Giulia Palazzo, Angelo Michele Carella, Mario Delia, Giovanni Pisapia, Domenico Pastore, Nicola Cascavilla, Vincenzo Pavone, Giorgina Specchia
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
Christina Hadjiaggelidou, Evdokia Mandala, Evangelos Terpos, Efthalia Yiannaki, Dimitra Markala, Theodora Triantafyllou, Athanasios Papatheodorou, Vassiliki Gkastari, Evgenia Verrou, Asimina Papanikolaou, Pavlina Konstantinidou, Eirini Katodritou
The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage
Linshu Zeng, Wenting Huang, Zheng Cao, Bo Zheng, Xiuyun Liu, Lei Guo, Xiaoli Feng
Allogeneic transplantation for high-risk chronic lymphocytic leukemia—a summary of a 16-year experience
Grzegorz Helbig, Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Mirosław Markiewicz, Małgorzata Kopera, Patrycja Zielińska, Krzysztof Woźniczka, Anna Kopińska, Iwona Grygoruk-Wiśniowska, Anna Koclęga
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study
Yves Soltermann, Dominik Heim, Michael Medinger, Helen Baldomero, Jörg P. Halter, Sabine Gerull, Christian Arranto, Jakob R. Passweg, Martina Kleber
Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience
Elisabetta Metafuni, Marianna Criscuolo, Teresa Spanu, Simona Sica
Retrospective analysis of thiamine deficiency in allogeneic stem cell transplant patients
Hannah Levavi, Doyun Park, Joshua Tannenbaum, Amir Steinberg
Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy
Masako Yokoo, Kensuke Kojima, Haruna Sano, Keita Kai, Fumiko Arakawa, Koichi Ohshima, Taketo Matsunaga, Shinya Kimura
Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma
Alessandra Serrao, Martina Canichella, Maria Lucia De Luca, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Alessandro Pulsoni
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis
Giovanni Martino, Andrea Marra, Stefano Ascani, Paolo Sportoletti
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia
Vlatko Pejsa, Marko Lucijanic, Zeljko Jonjic, Zeljko Prka, Gorana Vukorepa
Diffuse large B cell lymphoma and schistosomiasis: a rare simultaneous occurrence
Magda Zanelli, Maurizio Zizzo, Maria Cecilia Mengoli, Riccardo Valli, Giovanni Martino, Daniela Fenocchio, Loredana De Marco, Stefano Ascani
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?
Simon Haefliger, Dina Milowich, Amedeo Sciarra, Mounir Trimeche, Justine Bouilly, Julie Kaiser, Stephanie Volpi, Jean-Philippe Brouland, Christine Sempoux, Laurence de Leval
Synchronous follicular non-Hodgkin’s lymphoma and hairy cell leukaemia: a case report
Laura McDonald, K. Fadalla
Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma
Wolfgang Lamm, Barbara Kiesewetter, Hannah Puhr, Werner Dolak, Marius E. Mayerhöfer, Markus Raderer
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
Satoshi Yamasaki, Dai Chihara, Isao Yoshida, Kyuhei Kohda, Masashi Sawa, Hiroatsu Ago, Kazuto Togitani, Yuju Ohno, Junji Tanaka, Takahiro Fukuda, Yoshiko Atsuta, Junji Suzumiya, Ritsuro Suzuki
Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm
Chunli Yang, Chunxi Fu, You Feng, Sha Zhao, Huawei Weng, Li Zhang, Hongyan Du, Liqun Zou
Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation
Kristian Boasman, Matthew James Simmonds, Ciaren Graham, Yogen Saunthararajah, Ciro Roberto Rinaldi
Inhibitor eradication in refractory acquired hemophilia with lenalidomide
C. Pfrepper, W. Poenisch, M. Pierer, M. Metze, T. Kaiser, S. Petros